 | | | | KINSHASA (Reuters) - The head of the World Health Organization (WHO) on Tuesday cautioned against declaring victory too early in Congo's Ebola epidemic, despite encouraging signs that it may be brought under control. | | | | | | (Reuters) - Johnson & Johnson said on Tuesday it has accepted private equity firm Platinum Equity's $2.1 billion buyout offer for the company's LifeScan Inc unit. | | | | | | PARIS (Reuters) - Sanofi believes it can make a comeback and re-establish a leading position in the competitive cancer drug market on the back of its immunotherapy drugs and efforts in new areas such as molecular oncology. | | | | | | WASHINGTON (Reuters) - The U.S. Interior Department has been unable to adequately explain why it canceled a $1 million study on the public health impacts of mountaintop removal coal mining, the agency's inspector general office said in a report released on Tuesday. | | | | | | PARIS (Reuters) - French regulator ANSM said epilepsy drug valproate would face new restrictions across the European Union to protect pregnant women or of child-bearing age from exposing their babies to possible malformations and developmental problems. | | | | | | (Reuters Health) - A growing number of children are missing out on recommended vaccinations in states that permit parents to skip inoculations due to their personal beliefs even when there's no medical reason kids can't be vaccinated, a U.S. study suggests. | | | | | | BRASILIA (Reuters) - Brazilian prosecutors said on Tuesday that they were investigating a U.S. company for alleged 'biopiracy,' accusing it of illegally using genetic components of the tropical berry açaí in nutritional supplements it sells. | | | | | | (Reuters Health) - People who smoke or have diabetes may be more likely to have calcium deposits in brain regions crucial for memory, a Dutch study suggests. | | | | | | TEL AVIV (Reuters) - Israel's Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said on Tuesday it had positive results from a mid-stage study of its therapy to treat leg pain known as intermittent claudication (IC). | | | | | | SAN JOSE, Calif. (Reuters) - At its Silicon Valley headquarters, network gear maker Cisco Systems Inc is going to unusual lengths to take control of the relentless increase in its U.S. healthcare costs. | | | | | |
